Bunalict 8+2 mg resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bunalict 8+2 mg resoribletter, sublinguale

sandoz a/s - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg

Norvipren 200 mikrogram resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

norvipren 200 mikrogram resoribletter, sublinguale

sandoz a/s - buprenorphinhydrochlorid - resoribletter, sublinguale - 200 mikrogram

Temgesic 0,4 mg resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

temgesic 0,4 mg resoribletter, sublinguale

orifarm a/s - buprenorphinhydrochlorid - resoribletter, sublinguale - 0,4 mg

Buprenorphin/Naloxon "G.L. Pharma" 2+0,5 mg resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

buprenorphin/naloxon "g.l. pharma" 2+0,5 mg resoribletter, sublinguale

g.l. pharma gmbh - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg

Buprenorphin/Naloxon "G.L. Pharma" 8+2 mg resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

buprenorphin/naloxon "g.l. pharma" 8+2 mg resoribletter, sublinguale

g.l. pharma gmbh - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg

Buprenorphin/Naloxon "Mylan" 2+0,5 mg resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

buprenorphin/naloxon "mylan" 2+0,5 mg resoribletter, sublinguale

mylan ab - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg

Buprenorphin/Naloxon "Mylan" 8+2 mg resoribletter, sublinguale Denmark - Dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

buprenorphin/naloxon "mylan" 8+2 mg resoribletter, sublinguale

mylan ab - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg

Sixmo Uni Eropa - Dansk - EMA (European Medicines Agency)

sixmo

l. molteni & c. dei fratelli alitti società di esercizio s.p.a. - buprenorphin hydrochlorid - opioid-relaterede lidelser - andre narkotika stoffer - sixmo er angivet til substitutionsbehandling for opioidafhængighed i klinisk stabile voksne patienter, der kræver mere end 8 mg/dag af sublingual buprenorphin, inden for en ramme af medicinsk, social og psykologisk behandling.

Moventig Uni Eropa - Dansk - EMA (European Medicines Agency)

moventig

kyowa kirin holdings b.v. - naloxegol oxalat - constipation; opioid-related disorders - perifere opioid-receptor-antagonister, medicin mod forstoppelse - behandling af opioidinduceret forstoppelse (oic) hos voksne patienter, som har haft utilstrækkelig respons på afføringsmiddel (er).